34 results
424B5
SEEL
Seelos Therapeutics Inc
20 May 24
Prospectus supplement for primary offering
4:16pm
or economic downturn;
public health crises, pandemics, and epidemics, such as the COVID-19 pandemic;
sales of our common stock by us or our stockholders
424B5
SEEL
Seelos Therapeutics Inc
30 Jan 24
Prospectus supplement for primary offering
6:05am
pandemic;
sales of our common stock by us or our stockholders in the future; and
the trading volume of our common stock.
In addition, the stock
424B5
d79w dr20a8f
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
wbc0a32
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B5
4o7kr pxl1sowtjl
25 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
lodor3jot2z
12 May 22
Prospectus supplement for primary offering
8:30am
424B3
qcelh
27 Dec 21
Prospectus supplement
5:01pm